DK141955B - Fremgangsmåde til fremstilling af en pattegris-colibacillosisvaccine. - Google Patents
Fremgangsmåde til fremstilling af en pattegris-colibacillosisvaccine. Download PDFInfo
- Publication number
- DK141955B DK141955B DK652473AA DK652473A DK141955B DK 141955 B DK141955 B DK 141955B DK 652473A A DK652473A A DK 652473AA DK 652473 A DK652473 A DK 652473A DK 141955 B DK141955 B DK 141955B
- Authority
- DK
- Denmark
- Prior art keywords
- vaccine
- coli
- enterotoxin
- preparation
- hours
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title description 32
- 238000002360 preparation method Methods 0.000 title description 22
- 238000000034 method Methods 0.000 title description 14
- 241000588724 Escherichia coli Species 0.000 description 35
- 239000000147 enterotoxin Substances 0.000 description 29
- 231100000655 enterotoxin Toxicity 0.000 description 29
- 101710146739 Enterotoxin Proteins 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 239000002609 medium Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000007920 subcutaneous administration Methods 0.000 description 6
- 238000007918 intramuscular administration Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000003708 ampul Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 3
- 229960004906 thiomersal Drugs 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000000369 enteropathogenic effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 2
- 229940059904 light mineral oil Drugs 0.000 description 2
- 229940053050 neomycin sulfate Drugs 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 239000012449 sabouraud dextrose agar Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- PJSFRIWCGOHTNF-UHFFFAOYSA-N Sulphormetoxin Chemical compound COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC PJSFRIWCGOHTNF-UHFFFAOYSA-N 0.000 description 1
- 230000000240 adjuvant effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- -1 aluminum compound Chemical class 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000002298 density-gradient ultracentrifugation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000013094 purity test Methods 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004673 sulfadoxine Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31199872A | 1972-12-04 | 1972-12-04 | |
| US31199872 | 1972-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK141955B true DK141955B (da) | 1980-07-28 |
Family
ID=23209403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK652473AA DK141955B (da) | 1972-12-04 | 1973-12-03 | Fremgangsmåde til fremstilling af en pattegris-colibacillosisvaccine. |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS5713527B2 (cs) |
| BE (1) | BE808122A (cs) |
| CA (1) | CA1018889A (cs) |
| CH (1) | CH590928A5 (cs) |
| DD (1) | DD109029A5 (cs) |
| DE (1) | DE2360118C3 (cs) |
| DK (1) | DK141955B (cs) |
| ES (1) | ES421094A1 (cs) |
| FR (1) | FR2208648B1 (cs) |
| GB (1) | GB1401588A (cs) |
| HK (1) | HK679A (cs) |
| HU (1) | HU169138B (cs) |
| IE (1) | IE38555B1 (cs) |
| MY (1) | MY7900152A (cs) |
| NL (1) | NL177079C (cs) |
| ZA (1) | ZA738364B (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2547224A1 (de) * | 1974-11-01 | 1976-05-13 | Sandoz Ag | Organische verbindungen, ihre verwendung und herstellung |
| GB1560934A (en) * | 1975-05-07 | 1980-02-13 | Unilever Ltd | Methods for the resistance of non-human mammals to gastro-intestinal disorders |
| FR2466251B1 (fr) * | 1979-10-03 | 1983-03-18 | Agronomique Inst Nat Rech | Vaccin animal anticolibacillaire, obtention et application |
| AU638970B2 (en) * | 1989-01-23 | 1993-07-15 | Auspharm International Limited | Vaccine composition |
| US10441717B2 (en) | 2014-04-15 | 2019-10-15 | Insulet Corporation | Monitoring a physiological parameter associated with tissue of a host to confirm delivery of medication |
| JP7072990B2 (ja) | 2018-06-22 | 2022-05-23 | 株式会社ミツトヨ | 測定装置および測定方法 |
| US11241532B2 (en) | 2018-08-29 | 2022-02-08 | Insulet Corporation | Drug delivery system with sensor having optimized communication and infusion site |
| EP4221781A2 (en) | 2020-10-02 | 2023-08-09 | Insulet Corporation | Fluid delivery device having multiple penetrating elements |
| WO2022133218A1 (en) | 2020-12-18 | 2022-06-23 | Insulet Corporation | Adhesive pad with a metallic coil for securing an on-body medical device |
| WO2022251642A1 (en) | 2021-05-28 | 2022-12-01 | Insulet Corporation | Spring-based status sensors |
| EP4101482A1 (en) | 2021-06-07 | 2022-12-14 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
-
1973
- 1973-10-31 ZA ZA738364*A patent/ZA738364B/xx unknown
- 1973-11-23 NL NLAANVRAGE7316050,A patent/NL177079C/xx not_active IP Right Cessation
- 1973-11-26 DD DD174889A patent/DD109029A5/xx unknown
- 1973-11-28 GB GB5518773A patent/GB1401588A/en not_active Expired
- 1973-11-29 IE IE2163/73A patent/IE38555B1/xx unknown
- 1973-12-01 JP JP13521573A patent/JPS5713527B2/ja not_active Expired
- 1973-12-03 CA CA187,197A patent/CA1018889A/en not_active Expired
- 1973-12-03 DE DE2360118A patent/DE2360118C3/de not_active Expired
- 1973-12-03 BE BE138428A patent/BE808122A/xx not_active IP Right Cessation
- 1973-12-03 DK DK652473AA patent/DK141955B/da unknown
- 1973-12-03 HU HUTE750A patent/HU169138B/hu unknown
- 1973-12-03 FR FR7343042A patent/FR2208648B1/fr not_active Expired
- 1973-12-03 ES ES421094A patent/ES421094A1/es not_active Expired
- 1973-12-04 CH CH1695073A patent/CH590928A5/xx not_active IP Right Cessation
-
1979
- 1979-01-04 HK HK6/79A patent/HK679A/xx unknown
- 1979-12-30 MY MY152/79A patent/MY7900152A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL177079B (nl) | 1985-03-01 |
| DE2360118C3 (de) | 1980-12-18 |
| DD109029A5 (cs) | 1974-10-12 |
| JPS5713527B2 (cs) | 1982-03-17 |
| IE38555L (en) | 1974-06-04 |
| DE2360118B2 (de) | 1980-04-30 |
| IE38555B1 (en) | 1978-04-12 |
| HK679A (en) | 1979-01-12 |
| CA1018889A (en) | 1977-10-11 |
| AU6236473A (en) | 1975-05-15 |
| ES421094A1 (es) | 1976-04-01 |
| GB1401588A (en) | 1975-07-16 |
| FR2208648A1 (cs) | 1974-06-28 |
| MY7900152A (en) | 1979-12-31 |
| NL7316050A (cs) | 1974-06-06 |
| HU169138B (cs) | 1976-09-28 |
| ZA738364B (en) | 1974-09-25 |
| CH590928A5 (cs) | 1977-08-31 |
| DE2360118A1 (de) | 1974-06-06 |
| FR2208648B1 (cs) | 1977-09-02 |
| NL177079C (nl) | 1985-08-01 |
| BE808122A (fr) | 1974-06-04 |
| JPS4986530A (cs) | 1974-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9402902B2 (en) | Composition and method for the treatment and prevention of enteric bacterial infections | |
| CA1139663A (en) | Vaccine for diarrhea caused by e. coli | |
| US8637025B2 (en) | Composition and method for the treatment and prevention of enteric bacterial infections | |
| US4237115A (en) | Method of immunization against enterotoxogenic infection by Escherichia coli | |
| DK141955B (da) | Fremgangsmåde til fremstilling af en pattegris-colibacillosisvaccine. | |
| EA025766B1 (ru) | Липополисахарид ochrobactrum intermedium и его применение в качестве иммуностимулятора у млекопитающих | |
| KR890004019B1 (ko) | 요로 감염 치료용 백신의 제조방법 | |
| CA2104877C (en) | Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans | |
| US4053584A (en) | Pre-farrowing pregnant sow piglet colibacillosis vaccines and process for their administration to pregnant sows before farrowing | |
| JP6301945B2 (ja) | 子宮内疾患のためのワクチン | |
| US4443547A (en) | Animal vaccine against colibacillosis, preparation and use | |
| EP0127153A2 (en) | Bivalent vaccines | |
| NO169820B (no) | Fremgangsmaate for fremstilling av en mastittvaksine | |
| JPH05508407A (ja) | パスツレラ・ムルトシダのトキソイドワクチン | |
| US3401219A (en) | Moraxella bovis infectious bovine keratoconjunctivitis steam-killed bacterin | |
| US4472378A (en) | Live vaccine for the prevention of salmonellosis in water fowl, a process for making and applying the same | |
| EP0930316B1 (en) | Oral product for the prevention and treatment of infectious gastroenteritides in calves | |
| CN110862938B (zh) | 一株猪致病性大肠杆菌菌株及其灭活疫苗 | |
| Linggood et al. | Antibody induced elimination of the plasmid controlled K88 adhesion factor from a porcine enteropathogen | |
| KR101210082B1 (ko) | 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법 | |
| KR101209964B1 (ko) | 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법 | |
| RU1149467C (ru) | Вакцина против колибактериоза молодняка крупного рогатого скота и овец | |
| GB2062675A (en) | Immunogenic agents and vaccines from salmonella abortus and salmonella typhimurium | |
| RU2137499C1 (ru) | Ассоциированная вакцина против рота-, коронавирусной и эшерихиозной диареи новорожденных поросят | |
| NO135395B (cs) |